Skip to main content
SpringerLink
Log in

Inhibitors of Vascular Endothelial Growth Factor Receptor

  • Chapter
Cancer II

Part of the book series: Topics in Medicinal Chemistry ((TMC,volume 28))

Abstract

Angiogenesis-targeting agents, predominantly inhibitors of vascular endothelial growth factor and its receptors, have become a mainstay in oncology practice over the last decade. The approved drugs, which include two antibodies and seven small molecule inhibitors, represent strong validation for the field of anti-angiogenesis in the treatment of cancer. In addition to ongoing clinical studies assessing new indications for these agents, novel inhibitors are undergoing clinical evaluations and combination therapies of anti-angiogenic drugs with other targeted approaches are being investigated. This chapter will review the development of the currently marketed drugs targeting VEGFR, as well as the new inhibitors currently being assessed in the clinic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. FDA approved drug products. https://www.accessdata.fda.gov/scripts/cder/drugsatfda/

  2. Folkman J (2007) Nat Rev Drug Discov 6:273

    Article  CAS  Google Scholar 

  3. Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Cell Signal 19:2003

    Article  CAS  Google Scholar 

  4. Stuttfeld E, Ballmer-Hofer K (2009) IUBMB Life 61:915

    Article  CAS  Google Scholar 

  5. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) Nat Rev Mol Cell Biol 7:359

    Article  CAS  Google Scholar 

  6. Ferrara N (2011) Int J Dev Biol 55:383

    Article  Google Scholar 

  7. Ferrara N, Hillan KJ, Gerber H-P, Novotny W (2004) Nat Rev Drug Discov 3:391

    Article  CAS  Google Scholar 

  8. Gordon MS, Margolin K, Talpaz M, Sledge Jr GW, Holmgren E, Benjamin R, Stalter S, Shak S, Adelman D (2001) J Clin Oncol 19:843

    Article  CAS  Google Scholar 

  9. Lu JF, Bruno R, Eppler S, Novotny W, Lum B, Gaudreault J (2008) Cancer Chemother Pharmacol 62:779

    Article  CAS  Google Scholar 

  10. Keating GM (2014) Drugs 74:1891

    Article  CAS  Google Scholar 

  11. Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F (2005) J Clin Oncol 23:3502

    Article  CAS  Google Scholar 

  12. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH (2006) N Engl J Med 355:2542

    Article  CAS  Google Scholar 

  13. Escudier B, Bellmunt J, Négrier S, Bajetta E, Melichar B, Bracarda S, Ravaud A, Golding S, Jethwa S, Sneller V (2010) J Clin Oncol 28:2144

    Article  CAS  Google Scholar 

  14. Tewari KS, Sill MW, Long 3rd HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ (2014) N Engl J Med 370:734

    Article  CAS  Google Scholar 

  15. Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I (2014) J Clin Oncol 32:1302

    Article  CAS  Google Scholar 

  16. Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran Jr WJ, Mehta MP (2014) N Engl J Med 370:699

    Article  CAS  Google Scholar 

  17. Zalcman G, Mazières J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Janicot H, Gervais R, Locher C, Milleron B, Tran Q, Lebitasy MP, Morin F, Creveuil C, Parienti J-J, Scherpereel A (2015) J Clin Oncol 33(Suppl); abstr 7500

    Google Scholar 

  18. Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S (2006) Nat Rev Drug Discov 5:835

    Article  CAS  Google Scholar 

  19. Mangana J, Levesque MP, Karpova MB, Dummer R (2012) Exp Opin Invest Drugs 21:557

    Article  CAS  Google Scholar 

  20. McTigue MA, Wickersham JA, Pinko C, Showalter RE, Parast CV, Tempczyk-Russell A, Gehring MR, Mroczkowski B, Kan CC, Villafranca JE, Appelt K (1999) Structure 7:319

    Article  CAS  Google Scholar 

  21. McTigue M, Murray BW, Chen JH, Deng YL, Solowiej J, Kania RS (2012) Proc Natl Acad Sci U S A 109:18281

    Article  CAS  Google Scholar 

  22. Strumberg D, Richly H, Hilger RA, Schleucher N, Korfee S, Tewes M, Faghih M, Brendel E, Voliotis D, Haase CG, Schwartz B, Awada A, Voigtmann R, Scheulen ME, Seeber S (2005) J Clin Oncol 23:965

    Article  CAS  Google Scholar 

  23. Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai AA, Patnaik A, Xiong HQ, Rowinsky E, Abbruzzese JL, Xia C, Simantov R, Schwartz B, O’Dwyer PJ (2006) J Clin Oncol 24:2505

    Article  CAS  Google Scholar 

  24. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Staehler M, Negrier S, Chevreau C, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Anderson S, Hofilena G, Shan M, Pena C, Lathia C, Bukowski RM (2009) J Clin Oncol 27:3312

    Article  CAS  Google Scholar 

  25. Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C (2006) Cancer Res 66:11851

    Article  CAS  Google Scholar 

  26. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) N Engl J Med 359:378

    Article  CAS  Google Scholar 

  27. Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ (2014) Lancet 384:319

    Article  CAS  Google Scholar 

  28. Sun CL, Christensen JG, McMahon G (2009) Discovery and development of sunitinib (SU11248): a multitarget tyrosine kinase inhibitor of tumor growth, survival, and angiogenesis. In: Li R, Stafford JA (eds) Kinase inhibitor drugs. Wiley, Hoboken, p. 1

    Google Scholar 

  29. Britten CD, Kabbinavar F, Hecht JR, Bello CL, Li J, Baum C, Slamon D (2008) Cancer Chemother Pharmacol 61:515

    Article  CAS  Google Scholar 

  30. Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N, Bello C, Deprimo S, Brega N, Massimini G, Armand JP, Scigalla P, Raymond E (2006) J Clin Oncol 24:25

    Article  CAS  Google Scholar 

  31. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA (2007) N Engl J Med 356:115

    Article  CAS  Google Scholar 

  32. Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG (2006) Lancet 368:1329

    Article  CAS  Google Scholar 

  33. Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P (2011) N Engl J Med 364:501

    Article  CAS  Google Scholar 

  34. Harris PA, Stafford JA (2009) Discovery of pazopanib, a pan vascular endothelial growth factor kinase inhibitor. In: Li R, Stafford JA (eds) Kinase inhibitor drugs. Wiley, Hoboken, p. 57

    Chapter  Google Scholar 

  35. Kumar R, Knick VB, Rudolph SK, Johnson JH, Crosby RM, Crouthamel MC, Hopper TM, Miller CG, Harrington LE, Onori JA, Mullin RJ, Gilmer TM, Truesdale AT, Epperly AH, Boloor A, Stafford JA, Luttrell DK, Cheung M (2007) Mol Cancer Ther 6:2012

    Article  CAS  Google Scholar 

  36. Hurwitz H, Dowlati A, Savage S, Fernando N, Lasalvia S, Whitehead B, Suttle B, Collins D, Ho P, Pandite L (2005) J Clin Oncol 23:3012

    Article  Google Scholar 

  37. Hutson TE, Davis ID, Machiels JH, de Souza PL, Baker K, Bordogna W, Westlund R, Crofts T, Pandite L, Figlin RA (2008) J Clin Oncol 26:5046

    Article  Google Scholar 

  38. Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, Barrios CH, Salman P, Gladkov OA, Kavina A, Zarbá JJ, Chen M, McCann L, Pandite L, Roychowdhury DF, Hawkins RE (2010) J Clin Oncol 28:1061

    Article  CAS  Google Scholar 

  39. Sleijfer S, Papai Z, Le Cesne A, Scurr M, Ray-Coquard I, Collin F, Pandite L, Marreaud S, De Brauwer A, Blay J (2007) J Clin Oncol 25:10031

    Google Scholar 

  40. van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, Le Cesne A, Gelderblom H, Judson IR, Araki N, Ouali M, Marreaud S, Hodge R, Dewji MR, Coens C, Demetri GD, Fletcher CD, Dei Tos AP, Hohenberger P (2012) Lancet 379:1879

    Article  Google Scholar 

  41. Kania RS (2009) Structure-based design and characterization of axitinib. In: Li R, Stafford JA (eds) Kinase inhibitor drugs. Wiley, Hoboken, p. 167

    Chapter  Google Scholar 

  42. Rugo HS, Herbst RS, Liu G, Park JW, Kies MS, Steinfeldt HM, Pithavala YK, Reich SD, Freddo JL, Wilding G (2005) J Clin Oncol 23:5474

    Article  CAS  Google Scholar 

  43. Rini BI, Wilding G, Hudes G, Stadler WM, Kim S, Tarazi J, Rosbrook B, Trask PC, Wood L, Dutcher JP (2009) J Clin Oncol 27:4462

    Article  CAS  Google Scholar 

  44. Motzer RJ, Escudier B, Tomczak P, Hutson TE, Michaelson MD, Negrier S, Oudard S, Gore ME, Tarazi J, Hariharan S, Chen C, Rosbrook B, Kim S, Rini BI (2013) Lancet Oncol 14:552

    Article  CAS  Google Scholar 

  45. Spano J, Chodkiewicz C, Maurel J, Wong RP, Wasan HS, Pithavala YK, Bycott PW, Liau K, Kim S, Rixe O (2007) J Clin Oncol 25:4551

    Google Scholar 

  46. Kindler HL, Ioka T, Richel DJ, Bennouna J, Létourneau R, Okusaka T, Funakoshi A, Furuse J, Park YS, Ohkawa S, Springett GM, Wasan HS, Trask PC, Bycott P, Ricart AD, Kim S, Van Cutsem E (2011) Lancet Oncol 12:256

    Article  CAS  Google Scholar 

  47. Davis SL, Eckhardt SG, Messersmith WA, Jimeno A (2013) Drugs Today 49:105

    Article  CAS  Google Scholar 

  48. Mross K, Frost A, Steinbild S, Hedbom S, Büchert M, Fasol U, Unger C, Krätzschmar J, Heinig R, Boix O, Christensen O (2012) Clin Cancer Res 18:2658

    Article  CAS  Google Scholar 

  49. Grothey A, Sobrero AF, Siena S, Falcone A, Ychou M, Lenz H-J, Yoshino T, Cihon F, Wagner A, Van Cutsem E (2012) J Clin Oncol 30(Suppl 4); abstr LBA385

    Google Scholar 

  50. Demetri GD, Reichardt P, Kang Y-K, Blay J-Y, Joensuu H, Maki RG, Rutkowski P, Hohenberger P, Gelderblom H, Leahy MG, von Mehren M, Schoffski P, Blackstein ME, Le Cesne A, Badalamenti G, Xu J-M, Nishida T, Laurent D, Kuss I, Casali PG (2012) J Clin Oncol 30(Suppl); abstr LBA10008

    Google Scholar 

  51. Bruix J, Tak WY, Gasbarrini A, Santoro A, Colombo M, Lim HY, Mazzaferro V, Wiest R, Reig M, Wagner A, Bolondi L (2013) Eur J Cancer 49:3412

    Article  CAS  Google Scholar 

  52. Roth GJ, Binder R, Colbatzky F, Dallinger C, Schlenker-Herceg R, Hilberg F, Wollin SL, Kaiser R (2015) J Med Chem 58:1053

    Article  CAS  Google Scholar 

  53. Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ (2008) Cancer Res 68:4774

    Article  CAS  Google Scholar 

  54. Matsui J, Yamamoto Y, Funahashi Y, Tsuruoka A, Watanabe T, Wakabayashi T, Uenaka T, Asada M (2008) Int J Cancer 122:664

    Article  CAS  Google Scholar 

  55. Okamoto K, Ikemori-Kawada M, Jestel A, von König K, Funahashi Y, Matsushima T, Tsuruoka A, Inoue A, Matsui J (2014) ACS Med Chem Lett 6:89

    Article  Google Scholar 

  56. Nakamichi S, Nokihara H, Yamamoto N, Yamada Y, Honda K, Tamura Y, Wakui H, Sasaki T, Yusa W, Fujino K, Tamura T (2015) Cancer Chemother Pharmacol 76:1153

    Article  CAS  Google Scholar 

  57. Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI (2015) N Engl J Med 372:621

    Article  Google Scholar 

  58. Sorbera LA, Serradell N, Rosa E, Bolós J, Bayés M (2007) Drugs Future 32:577

    Article  CAS  Google Scholar 

  59. Schmidt C (2015) J Natl Cancer Inst 107:3

    Google Scholar 

  60. Sahade M, Caparelli F, Hoff PM (2012) Future Oncol 8:775

    Article  CAS  Google Scholar 

  61. Haberkorn BC, Eskens FA (2013) Future Oncol 9:13

    Article  CAS  Google Scholar 

  62. Jamil MO, Hathaway A, Mehta A (2015) Curr Oncol Rep 17:24

    Article  Google Scholar 

  63. Benson A, Krivoshik A, Van Sant C, Needle M (2015) Ann Oncol 26(Suppl 4):108

    Article  Google Scholar 

  64. Porta C, Giglione P, Liguigli W, Paglino C (2015) Future Oncol 11:39

    Article  CAS  Google Scholar 

  65. Tian S, Quan H, Xie C, Guo H, Lü F, Xu Y, Li J, Lou L (2011) Cancer Sci 102:1374

    Article  CAS  Google Scholar 

  66. Scagliotti GV, Vynnychenko I, Park K, Ichinose Y, Kubota K, Blackhall F, Pirker R, Galiulin R, Ciuleanu TE, Sydorenko O, Dediu M, Papai-Szekely Z, Banaclocha NM, McCoy S, Yao B, Hei YJ, Galimi F, Spigel DR (2012) J Clin Oncol 30:2829

    Article  CAS  Google Scholar 

  67. Johnson PJ, Qin S, Park JW, Poon RT, Raoul JL, Philip PA, Hsu CH, Hu TH, Heo J, Xu J, Lu L, Chao Y, Boucher E, Han KH, Paik SW, Robles-Aviña J, Kudo M, Yan L, Sobhonslidsuk A, Komov D, Decaens T, Tak WY, Jeng LB, Liu D, Ezzeddine R, Walters I, Cheng AL (2013) J Clin Oncol 31:3517

    Article  CAS  Google Scholar 

  68. Llovet JM, Decaens T, Raoul JL, Boucher E, Kudo M, Chang C, Kang YK, Assenat E, Lim HY, Boige V, Mathurin P, Fartoux L, Lin DY, Bruix J, Poon RT, Sherman M, Blanc JF, Finn RS, Tak WY, Chao Y, Ezzeddine R, Liu D, Walters I, Park JW (2013) J Clin Oncol 31:3509

    Article  CAS  Google Scholar 

  69. Siu LL, Shapiro JD, Jonker DJ, Karapetis CS, Zalcberg JR, Simes J, Couture F, Moore MJ, Price TJ, Siddiqui J, Nott LM, Charpentier D, Liauw W, Sawyer MB, Jefford M, Magoski NM, Haydon A, Walters I, Ringash J, Tu D, O’Callaghan CJ (2013) J Clin Oncol 31:2477

    Article  CAS  Google Scholar 

  70. Cainap C, Qin S, Huang WT, Chung IJ, Pan H, Cheng Y, Kudo M, Kang YK, Chen PJ, Toh HC, Gorbunova V, Eskens FA, Qian J, McKee MD, Ricker JL, Carlson DM, El-Nowiem S (2015) J Clin Oncol 33:172

    Article  CAS  Google Scholar 

  71. Sobrero AF, Bruzzi P (2011) J Clin Oncol 29:1938

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GlaxoSmithKline Inc., Collegeville, PA, USA

    Philip A. Harris

Authors
  1. Philip A. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip A. Harris .

Editor information

Editors and Affiliations

  1. Northern Institute for Cancer Research, Chemistry, Newcastle University, Newcastle upon Tyne, UK

    Michael J. Waring

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Harris, P.A. (2017). Inhibitors of Vascular Endothelial Growth Factor Receptor. In: Waring, M.J. (eds) Cancer II. Topics in Medicinal Chemistry, vol 28. Springer, Cham. https://doi.org/10.1007/7355_2016_28

Download citation

Publish with us

Policies and ethics

Search

Navigation